Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.25 GBX | -2.99% | -23.53% | -76.79% |
04-25 | Transcript : Destiny Pharma plc, 2023 Earnings Call, Apr 25, 2024 | |
04-25 | AIM WINNERS & LOSERS: Kromek jumps 14% on US government contract | AN |
Business Summary
Number of employees: 24
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 31/08/23 | |
William Love
FOU | Founder | 62 | 03/03/96 |
Shaun Claydon
DFI | Director of Finance/CFO | 56 | 23/10/18 |
Jim Lees
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/16 |
Chief Tech/Sci/R&D Officer | - | 31/12/97 | |
Yuri Martina
CTO | Chief Tech/Sci/R&D Officer | - | 02/05/22 |
Director/Board Member | 61 | 31/12/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Rudd
CHM | Chairman | 76 | 31/08/11 |
William Love
FOU | Founder | 62 | 03/03/96 |
Nigel Brooksby
BRD | Director/Board Member | - | 31/05/22 |
Shaun Claydon
DFI | Director of Finance/CFO | 56 | 23/10/18 |
Director/Board Member | 61 | 31/12/19 | |
James Stearns
BRD | Director/Board Member | - | 31/05/22 |
Aled Williams
BRD | Director/Board Member | - | 31/05/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 95,311,863 | 71,818,619 ( 75.35 %) | 0 | 75.35 % |
Company contact information
Destiny Pharma Plc
Sussex Innovation Centre Science Park Square
BN1 9SB, Brighton
+44 1273 704440
http://www.destinypharma.comSector
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-76.79% | 19.29M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- DEST Stock
- Company Destiny Pharma plc